Yipeng Ding Selected Research

Interleukins

1/2023

Suggestive evidence of genetic association of IL23R polymorphisms with chronic obstructive pulmonary disease risk in the Chinese population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yipeng Ding Research Topics

Disease

19	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2015
4	Neoplasms (Cancer) 07/2022 - 09/2017
2	Lung Neoplasms (Lung Cancer) 01/2019 - 08/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2017 - 03/2017
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Leukemia 01/2020
1	Asthma (Bronchial Asthma) 06/2015
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015
1	Cough 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Hypoxia (Hypoxemia) 01/2015

Drug/Important Bio-Agent (IBA)

3	Long Noncoding RNAIBA 07/2022 - 03/2017
3	ORALIT (ORS)IBA 10/2020 - 08/2016
2	LipopolysaccharidesIBA 01/2024 - 07/2022
2	AcidsIBA 01/2024 - 11/2020
2	NucleotidesIBA 01/2020 - 03/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 01/2015
1	Circular RNAIBA 01/2024
1	Peptides (Polypeptides)IBA 01/2024
1	peimisineIBA 01/2024
1	AnnexinsIBA 01/2023
1	InterleukinsIBA 01/2023
1	Messenger RNA (mRNA)IBA 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	Competitive Endogenous RNAIBA 07/2022
1	Nicotine FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	EnzymesIBA 11/2020
1	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 11/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020
1	Cytochrome P-450 CYP3AIBA 11/2020
1	Cytochrome P-450 CYP2C9IBA 10/2020
1	Cytochrome P-450 CYP2C19IBA 10/2020
1	Vitamin D3 24-HydroxylaseIBA 01/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2019
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2019
1	Hypoxia-Inducible Factor 1IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	GoldIBA 01/2018
1	AdiponectinIBA 06/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2015
1	Cholinergic ReceptorsIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	SmokeIBA 01/2015
1	Charcoal (Charbon)IBA 01/2015
1	Petroleum (Crude Oil)IBA 01/2015
1	Iron Regulatory Protein 2IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Natural Gas (Gas, Natural)IBA 01/2015

Therapy/Procedure

1	Local Anesthesia 01/2022